Analyst Ratings for Moderna (MRNA )

MRNA Rating Summary

MRNA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MRNA
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $85.28 (-55.1%) * Over Last 12-Mos
Rating Score: 2.3 / 10   Percentile Rank: 17%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/30/2026 Citi Geoff Meacham Downgrade Sell
(Neutral)
80.00
(60.00)
203.46
(190.01)
-6.61% Details
9/3/2026 Rothschild Redburn Simon Baker Downgrade Sell
(Neutral)
81.00
(40.00)
154.27
(190.01)
23.17% Details